Ensign Peak Advisors, Inc - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ensign Peak Advisors, Inc ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$21,479,000
+22.3%
124,807
-10.8%
0.04%
+28.6%
Q2 2021$17,562,000
+2.7%
139,948
+11.0%
0.04%
-5.4%
Q1 2021$17,100,000
+35.0%
126,102
+27.4%
0.04%
+27.6%
Q4 2020$12,665,000
-5.4%
98,987
-16.8%
0.03%
-14.7%
Q3 2020$13,394,000
+40.9%
119,024
+19.3%
0.03%
+30.8%
Q2 2020$9,507,000
+19.0%
99,779
+12.3%
0.03%
-3.7%
Q1 2020$7,987,000
+55.1%
88,889
-8.5%
0.03%
+92.9%
Q4 2019$5,151,00097,1700.01%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 42,030$3,777,0006.01%
Artal Group S.A. 1,500,000$134,805,0005.70%
GREAT POINT PARTNERS LLC 535,627$48,137,0005.03%
KINGDON CAPITAL MANAGEMENT, L.L.C. 211,038$18,966,0003.47%
Cormorant Asset Management, LP 825,000$74,143,0003.44%
Graticule Asia Macro Advisors LLC 48,700$4,377,0003.20%
Avoro Capital Advisors LLC 860,000$77,288,0002.61%
QVT Financial LP 120,264$10,808,0002.52%
Ikarian Capital, LLC 316,900$28,480,0002.14%
Avidity Partners Management LP 166,000$14,918,0002.06%
View complete list of ACCELERON PHARMA INC shareholders